BRIEF-Aptose Biosciences Reports Qtrly Loss Per Share $0.17
BRIEF-Aptose Biosciences Reports Qtrly Loss Per Share $0.17
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020
* APTOSE BIOSCIENCES INC - ANNOUNCES RESIGNATION OF CFO GREGORY CHOW
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.17
* APTOSE BIOSCIENCES INC - TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31, 2020 WERE $122.4 MILLION
* APTOSE BIOSCIENCES - EXPECTS CASH ON HAND, AVAILABLE CAPITAL PROVIDE CO WITH SUFFICIENT RESOURCES TO FUND OPERATIONS INTO H1 2023
Source text for Eikon: Further company coverage:
March 23 (Reuters) - Aptose Biosciences Inc APS.TO :
路透3月23日电-Aptose生物科学公司APS.TO：
* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2020
*Aptose报告2020年第四季度和全年业绩
* APTOSE BIOSCIENCES INC - ANNOUNCES RESIGNATION OF CFO GREGORY CHOW
*Aptose Biosciences Inc-宣布CFO Gregory Chow辞职
* APTOSE BIOSCIENCES INC - QTRLY LOSS PER SHARE $0.17
*Aptose Biosciences Inc-每股季度亏损0.17美元
* APTOSE BIOSCIENCES INC - TOTAL CASH AND CASH EQUIVALENTS AND INVESTMENTS AS OF DECEMBER 31, 2020 WERE $122.4 MILLION
*Aptose Biosciences Inc-截至2020年12月31日，现金和现金等价物以及投资总额为1.224亿美元
* APTOSE BIOSCIENCES - EXPECTS CASH ON HAND, AVAILABLE CAPITAL PROVIDE CO WITH SUFFICIENT RESOURCES TO FUND OPERATIONS INTO H1 2023
*Aptose Biosciences-预计手头有现金，可用资金为CO提供足够的资源，为2023年上半年的运营提供资金
Source text for Eikon: Further company coverage:
Eikon的源文本：进一步的公司报道：
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧